Lupin partnered with SteinCares to commercialize its ranibizumab biosimilar throughout Latin America (excluding Mexico & Argentina). SteinCares will manage regulatory & commercial aspects, while Lupin handles manufacturing.
Cyient-Zinier Team Up for FSM Boost
RateGain Powers Green Motion Growth
Indian Mutual Funds Foreign Assets Drop
Malaysia Extends Biocon Biologics Insulin Contract
Swiggy, Eternal Rally on Margin Hopes
Reliance Unveils AI-Powered Digital Future
TCS & DNA Cloud Partnership
News that matters the most ⚡